U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309471) titled 'Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD' on Dec. 15.
Brief Summary: This study investigates DDH-LSD, a novel LSD-like compound expected to have a shorter duration of action than LSD. In healthy volunteers, pharmacokinetics, safety, and subjective effects, will be assessed and compare with LSD in a controlled cross-over study.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
LSD Reaction
Intervention:
DRUG: DDH-LSD
Single oral dose of DDH-LSD at the dose determined in Substudy 1. Participants are monitored for 13 hours for pharmacokinetics, subjective effects, autonomic responses, and sa...